Evidence map›Paper›PMID 40964401›Full record

ArticlebioRxiv : the preprint server for biology2025

Versatile HIV Rev-dependent reporter cell system for stringent and sensitive quantification of viral reservoirs, neutralizing antibodies, and restriction factors.

Mark Spear, Joseph Choi, Brian Hetrick, JeongHwan Lee, Gabrielle Lê-Bury, Thuy T Vo, Yang Han, Huizhi Liang, Jia Guo, Dongyang Yu and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Mark SpearCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Joseph ChoiDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Brian HetrickCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
JeongHwan LeeDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Gabrielle Lê-BuryDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Thuy T VoCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Yang HanCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Huizhi LiangCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Jia GuoCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Dongyang YuCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Subashini IyerCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.
Henry C MwandumbaMalawi-Liverpool-Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
David G RussellDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.ORCID 0000-0002-9748-750X
Yuntao WuCenter for Infectious Disease Research, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0002-9547-3278
David W GludishDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.ORCID 0000-0002-3537-4585

Funding

Mechanisms of PSGL-1 restriction of HIV virion infectivityR01AI148012 · NIAID · GEORGE MASON UNIVERSITY · PI YUNTAO WU · 2020 to 2026
$5.0M
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.R01AI176575 · NIAID · CORNELL UNIVERSITY · PI DAVID G RUSSELL · 2023 to 2026
$2.3M
Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failureK01OD031968 · OD · CORNELL UNIVERSITY · PI David W Gludish · 2022 to 2026
$769k
The Unilateral Mosaic (UMos): Novel tools to compartmentalize pathology and trace cellular interactions in mouse models of human diseaseR21OD037879 · OD · CORNELL UNIVERSITY · PI GLUDISH, DAVID W · 2024 to 2025
$432k
NIAID NIH HHS R01 AI148012NIAID NIH HHS R01 AI176575NIH HHS K01 OD031968NIH HHS R21 OD037879Wellcome Trust
6 · The paper itself

Abstract

Detecting and measuring HIV reservoirs, neutralizing antibodies, and restriction factors are important for HIV cure research and the development of new therapeutics and vaccines. Here we describe the development and validation of several HIV Rev-dependent indicator cell lines for these purposes. These reporter cells come from different T-lymphoblast cell lines, including MOLT-4-R5, SupT1-R5, CEM-SS, A3R5, and from the adherent TZM cell platform based on HeLa clone JC53. These cells express CD4, CXCR4, and various levels of CCR5. We compared these cell lines for responsiveness to both X4 and R5-tropic viruses, and confirmed that reporter expression in these cells is not affected by stimulation from mitogens but is responsive to HIV Tat and Rev, reducing non-specific reporter induction from the leaky LTR promoter. To validate the sensitivity of the Rev-dependent reporter cell systems, we conducted a viral dilution assay with three primary HIV-1 clade C swarms from an adult in Malawi. We also validated the systems for quantifying antibody neutralization and screening restriction factors; these systems are also sensitive for viral outgrowth assays for quantifying viral reservoirs in clinical and basic research settings. Given that the systems can measure HIV accurately in complex environments with mitogens or other substances, they can be used for versatile applications, such as quantifying latent reservoirs, testing inhibitory compounds, conducting neutralizing antibody assays, and identifying new restriction factors.

Identifiers

PMID40964401
PMCPMC12439932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.